Adenomatous polyposis coli, protein kinases, protein tyrosine phosphatase: the effect of sulindac

W R Waddell1, R L Miesfeld

  • 1Department of Surgery, University of Arizona, Tucson, USA.

Insights

Sulindac reverses defects in adenomatous polyps by inhibiting cyclooxygenase-1, restoring cell communication and normal function. This drug normalizes prostaglandin levels, cAMP synthesis, and protein kinase A activity.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Oncology

Background:

  • Adenomatous polyps are associated with mutations in the APC gene.
  • Mutant APC leads to high prostaglandin levels, desensitization of adenylate cyclase, and inactivation of protein kinase A (PKA).
  • This results in cellular isolation, overphosphorylation, and loss of corrective capabilities.

Purpose of the Study:

  • To present a putative explanation for sulindac's effect on adenomatous polyps.
  • To elucidate the molecular mechanisms underlying polyp formation and sulindac's therapeutic action.

Main Methods:

  • Clinical observations and in vitro experiments.
  • Analysis of cellular signaling pathways, including cAMP synthesis, PKA activity, and MAP kinase cascade.
  • Investigation of gene transcription and protein phosphorylation states.

Main Results:

  • Sulindac, by inhibiting cyclooxygenase-1, reverses abnormalities caused by mutant APC.
  • Restoration of normal cAMP synthesis and PKA activity.
  • PKA re-establishes control over Raf-1 kinase, MAP kinase cascade, and immediate early gene transcription, while stimulating protein tyrosine phosphatase (PTPase).

Conclusions:

  • Sulindac normalizes the phosphorylation state of cellular proteins.
  • Restores cell-cell communication, adherence, and epithelial structure.
  • Circumvents the transformed phenotype of mutant cells, potentially aiding in polyp regression.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...